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IgE Autoimmunity: A Pathogenic Factor in Atopic Dermatitis? 
Valenta et a1 @. 203) suggest that IgE autoreactivity may contribute antibodies against human proteins in sera from indivi 
human proteins. The significance of this latter hnding has long been speculate that the tendency to develop IgE autoreactivi 
puzzling to immunologists. Noting that there are structural resem- differentiate atopic patients with skin disease from those kee 
blances between some environmental allergens and human pro- disease and that the reactivity hetp sustain and perpetuate 
teins, and to test the possibility that IgE reactivity to endogenous matory skin lesions in atopic patients. In this scenario, IgE 
proteins may be involved in atopic skin disease, Valenta et a1 tested activity. independent of exogenous allergic stimuli, could 
manifestations for IgE reactivity to human proteins. Using West- a sort of autoimmunity, could be an underlying cause, a tri 
em-blotted extracts from human cell lines, they detected IgE factor, or both, for atopic dermatitis. 
The Therapeutic Basis of PUVA in CTCL: Apoptosis? 
In studies of the mechanism by which P W A  is therapeutic in speculate that other means of inducing apoptosis 
cutaneous T cell lymphoma, the investigators exposed T lympho- therapeutically useful. Also, they suggest that the 
combination, or PWA.  Psoralen alone was without effect. Apo- radiation, even hl temperate climates, to which people ar 
No Need for Langerhans Cells in the Induction of Tolerance to Contact Allergens + 
Steinbrink et a1 (p. 243) show that Langerhans cells are not involved investigators found that various treatments known t 
in the induction of tolerance that develops when small amounts of erhans cells did not affect the induction of tolerance. 
contact allergens are applied to skin of mice. The mechanism by the investigators inhibited Langerhans cell function 
which tolerance is induced by small amounts of topically applied the skin with ultraviolet light and by painting a sensi 
haptens is not well understood. When contact allergens are applied on the same site, but tolerance could still be induced. 
Langerhans cells are demonstrable by electron microscopy, clearly findings is that low doses of contact allergens 
indicating that the allergen affects Langerhans cells. Amounts of rapidly without affecting Langerhans cells an 
allergen too low to sensitize, on the other hand, induce tolerance to tissue directly. The authors have previously 
the induction of tolerance fiom cutaneously applied haptens. The means. 
